Knowledge Distillery

Experience in multiple sclerosis patients with COVID-19 and disease-modifying therapies: a review of 873 published cases

Complications and pathophysiology of COVID-19 in the Nervous System

COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments

COVID-19, de novo seizures, and epilepsy: a systematic review

SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation

COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management

Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia

COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management

The cognitive consequences of the COVID-19 epidemic: collateral damage?

Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown

Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses